Table 2 Adverse effects in patients with COVID-19 by patient group
From: Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study
LPV/r group (n = 22) | Combination group (n = 19) | P-value | |
|---|---|---|---|
Decreased white blood cell count, n (%) | 3 (13.6) | 3 (15.8) | 1.000 |
Elevated transaminase, n (%) | 6 (27.3) | 5 (26.3) | 0.945 |
Mild anemia, n (%) | 2 (9) | 0 (0) | 0.490 |
Transient fever, n (%) | 1 (4.5) | 3 (15.8) | 0.495 |
Digestive upsets, n (%) | 6 (27.3) | 5 (26.3) | 0.945 |